Imperial Tobacco's (IMT) full-year trading update confirmed a continuation of recent trends, including resiliency in core markets thanks to a value-focused product portfolio and strength across emerging markets in Asia and Eastern Europe. In aggregate, the firm expects total revenue to increase 2% for the full year (using constant currencies) despite a collective 2% decrease in cigarette and fine-cut tobacco volume, slightly ahead of our expectations but not material enough to revise to our fair value estimates. Spain--where Imperial controls about 30% of the tobacco market--remains an area of weakness because of macroeconomic and regulatory pressures.
After rallying the past few weeks, Imperial's stock trades just below our fair value estimate but remains the most attractively valued tobacco name in our coverage list, along with Lorillard (LO).
This is an excerpt from the Morningstar Research Report for Imperial Tobacco. Read the full report here. Morningstar Research is available to Premium subscribers.
SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk
To view this article, become a Morningstar Basic member.
Register For Free
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.